|
|
|
|
|
|
|
|
|
|
Rv1908c More about Rv1908c on TBDB.org More about Rv1908c on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv1908c: Codons 60 to 79: 12 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Siddiqi N AAC 2002 | GCG/ACG | 181 | 61 | Ala/Thr | 1995-1998 | India | Sequencing | nt 3-239 & 1187-1600 | HRO | 10ug/ml R, 1ug/ml I, 2ug/ml O | Proportion method | 74/126 | 1/0 | R463L KatG, S95T gyrA, S531L rpo | - |
| Siddiqi N AAC 2002 | ins C | 185 | 62 | Truncation | 1995-1998 | India | Sequencing | nt 3-239 & 1187-1600 | HRS,HO,HR | 10ug/ml R, 1ug/ml I 2ug/ml O | Proportion method | 74/126 | 3/0 | S531W rpo, K121K rpsL, S95T gyrA,H526R rpo | - |
| Rouse DA AAC 1995 | GAC/GAA | 189 | 63 | Asp/Glu | 1995 | USA, South Korea | PCR-SSCP, Sequencing | Whole gene | H | 50ug/ml | Absolute concentration method. | 26/26 | 1/0 | - | - |
| Marttila HJ AAC 1996 | ins CCCC | 195 | 65 | Frameshift | 1989-1995 | Finland | Sequencing | Whole gene | H | 1ug/ml | Disk elution method | 54/56 | 1/0 | - | - |
| Cockerill FR JID 1995 | GCC/ACC | 193 | 65 | Ala/Thr | 1995 | USA | PCR, RFLP, Sequencing. | Whole gene | H | 0.25ug/ml | Proportion method | 40071 | 0/1 | Ala66Pro and others in katG. | - |
| Cockerill FR JID 1995 | GCG/CCG | 196 | 66 | Ala/Pro | 1995 | USA | Sequencing | Whole gene | H | 0.25ug/ml | Proportion method | 40071 | 0/1 | Ala65Thr, Met126Ile, Ala243Ser, Asn258Ser, Ala264Thr, Tyr337Phe | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | ATC/AAC | 212 | 71 | Ile/Asn | - | - | - | - | - | - | - | - | - | - | - |
| Chan RCY JAC 2007 | GAC/GGC | - | 72 | Asp/Gly | 1994-2004 | Hong Kong | PCR-SSCP, Sequencing | Whole gene | N.S. | - | Absolute concentration method | 250 | 241 | 1 | - |
| Secondary Publication: Hazbon MH AAC 2006 | GAC/AAC | 214 | 72 | Asp/Lys | - | - | - | - | - | - | - | - | - | - | - |
| Siddiqi N AAC 2002 | GAC/AAC | ? | 73 | Asp/Asn | 1995 | India | Sequencing | nt 3-239 & 1187-1600 | H | 1ug/ml I | Proportion method | 74/126 | 1/0 | R463L KatG | - |
| Chan RCY JAC 2007 | GAC/TAC | 220 | 74 | Asp/Tyr | 1994-2004 | Hong Kong | PCR-SSCP, Sequencing | Whole gene | N.S. | - | Absolute concentration method | 250 | 241 | 1 | - |
| Chan RCY JAC 2007 | GAC/GGC | 221 | 74 | Asp/Gly | 1994-2004 | Hong Kong | PCR-SSCP, Sequencing | Whole gene | N.S. | - | Absolute concentration method | 250 | 241 | 1 | - |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |